NCT03698097 (ch18Saxer) is a clinical trial of patient satisfaction survey in Patient Survey, sponsored by University Hospital, Basel, Switzerland.

Who is sponsoring NCT03698097?

NCT03698097 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT03698097?

Interventions in NCT03698097: patient satisfaction survey.

What condition does NCT03698097 study?

NCT03698097 studies Patient Survey.

Is NCT03698097 still recruiting?

NCT03698097 is currently completed. Last updated 31 March 2023.

Last reviewed 2023-03-31 · How we verify

NCT03698097: ch18Saxer

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient Surveys - What Patients Want

Completed Last updated 31 March 2023

What this trial tests

trial testing patient satisfaction survey in Patient Survey in 745 participants. Completed in 31 October 2016.

Timeline

1 August 2016

Primary endpoint
31 October 2016

31 October 2016

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Status	Completed
Study type	OBSERVATIONAL
Enrollment	745
Start date	1 August 2016
Primary completion	31 October 2016
Estimated completion	31 October 2016
Sites	1 location across Switzerland

Drugs / interventions tested

patient satisfaction survey

Conditions studied

Patient Survey — all drugs for Patient Survey →

Sponsor

University Hospital, Basel, Switzerland

Who can join

Eligibility, any sex, with Patient Survey. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to gain insight into patients' preferences considering satisfaction surveys, specifically asking for their most pressing topics and their preferred survey technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03698097 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 31 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03698097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing